Cardiopulmonary Bypass Circuit Coatings: Recent Advances and Future Perspectives
Review
DOI:
https://doi.org/10.5281/zenodo.18901724Anahtar Kelimeler:
Cardiopulmonary Bypass, Circuit Coatings, Hemocompatibility, Heparin Coating, Zwitterionic PolymersÖzet
Introduction: Cardiopulmonary bypass (CPB) circuits expose blood to non-physiological surfaces, leading to platelet activation, coagulation disturbances, complement activation, hemolysis, and systemic inflammation. Early-generation heparin-coated circuits reduced thrombin formation, decreased heparin requirements, and mitigated inflammatory responses, laying the foundation for modern hemocompatible devices.
Objective: This review aims to summarize recent advances in CPB circuit coatings, critically evaluate their hemocompatibility, and highlight emerging strategies that enhance blood compatibility and reduce complications during extracorporeal circulation.
Method: Literature from the past decade was analyzed, focusing on polymer-based, zwitterionic, endothelial-mimetic, and nitric oxide–releasing coatings. Studies evaluating in vitro, preclinical, and clinical outcomes were considered, with emphasis on platelet activation, coagulation, complement activation, hemolysis, and inflammatory markers.
Results: Hydrophilic polymers such as PEG- and PMEA-based coatings reduced protein adsorption and platelet adhesion. Zwitterionic polymers demonstrated non-fouling properties under prolonged blood contact. Endothelial-mimetic coatings replicated vascular surface functions, enhancing hemocompatibility in preclinical models. Nitric oxide–releasing surfaces inhibited platelet activation and fibrin deposition. Improved hemocompatibility assessment using biomarkers including PF4, β-thromboglobulin, P-selectin, complement factors, and hemolysis indices enabled comparative evaluation of coating performance. Miniaturized extracorporeal circuits further decreased systemic inflammation and improved clinical outcomes.
Conclusion: Contemporary CPB circuit coatings substantially improve blood compatibility compared with uncoated circuits. While heparin-coated systems remain widely used, emerging polymeric, zwitterionic, endothelial-mimetic, and nitric oxide–releasing surfaces offer additional benefits. Ongoing research into hybrid multifunctional coatings, long-term durability, and clinical translation is essential to optimize CPB safety and physiological performance.
Referanslar
Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost. 2021;19(3):617–632. doi:10.1111/jth.15195
Akça E, Aydın MS, Padak M, Göz M, Dikme R, Göç Ö. Normotermik Kardiyopulmoner Bypass Sırasında Enflamasyon Parametrelerindeki değişiklikler İle Oksidatif Stresin Değerlendirilmesi. Dicle Tıp Dergisi. Mart 2020;47(1):223-231. doi:10.5798/dicletip.706148
Maisat W, Yuki K. Narrative review of systemic inflammatory response mechanisms in cardiac surgery and immunomodulatory role of anesthetic agents. Ann Card Anaesth. 2023;26(2):133–142. doi:10.4103/aca.aca_147_22
Yun SH, Sim EH, Goh RY, Park JI, Han JY. Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int. 2016;2016:9060143. doi:10.1155/2016/9060143
Hanedan MO, Yürük MA, Arslan AK, Kılıç A, Sayar U, Mataracı I. Heparin coated vs non coated cardiopulmonary bypass circuits: comparing immediate results with different target activated clotting time. Braz J Cardiovasc Surg. 2020;35(6):913–917. doi:10.21470/1678-9741-2019-0387
Lu Q, Hofferbert BV, Koo G, Malinauskas RA. In vitro shear stress–induced platelet activation: sensitivity of human and bovine blood. Artif Organs. 2013;37(10):894–903. doi:10.1111/aor.12143.
Krohn C, Hellstern P, Philipp A, Welz A, Bartmann P. Heparin-coated circuits: historical development and hemocompatibility. J Thorac Cardiovasc Surg. 1996;112(2):472–483. doi:10.1016/S0022-5223(96)70265-7.
Lee DU, Kayumov M, Park J, et al. Antibiofilm and antithrombotic hydrogel coating based on superhydrophilic zwitterionic carboxymethyl chitosan for blood-contacting devices. Bioact Mater. 2024;34:112–124. doi:10.1016/j.bioactmat.2023.12.009
Ng CS, Wan S, Yim AP, Arifi AA. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Chest. 2004;126(4):1235-1241. doi:10.1378/chest.126.4.1235.
Kefalogianni R, Kamani F, Gaspar M, et al. Complement activation during cardiopulmonary bypass and association with clinical outcomes. eJHaem. 2022;3(1):86-96. doi:10.1002/jha2.371.
Ueyama K, Nishimura K, Nishina T, Nakamura T, Ikeda T, Komeda M. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO J. 2004;50(4):369–372. doi:10.1097/01.MAT.0000130679.55946.4d
Ishihara K. Biomimetic materials based on zwitterionic polymers toward human friendly medical devices. Sci Technol Adv Mater. 2022;23(1):498–524. doi:10.1080/14686996.2022.2119883.
Biran R, Pond D. Heparin coatings for improving blood compatibility of medical devices. Adv Drug Deliv Rev. 2017;112:12–23. doi:10.1016/j.addr.2016.06.019.
Lax M, Pesonen E, Hiippala S, et al. Heparin dose and point-of-care measurements of hemostasis in cardiac surgery — results of a randomized controlled trial. J Cardiothorac Vasc Anesth. 2020;34(9):2362–2368. doi:10.1053/j.jvca.2019.12.050
Kim Y, Park H, Lee S, et al. Minimal extracorporeal circuits with heparin coating: impact on complement activation and clinical outcomes. Perfusion. 2018;33(7):555-563.
Ishihara K, Nakabayashi N, Saito T, et al. Platelet preservation on covalent heparin-coated surfaces: in vitro and clinical evaluation. Biomed Mater. 2017;12(2):025009. doi:10.1088/1748-605X/12/2/025009.
Elbardissi AW, Aranki SF, Adams DH, et al. Clinical outcomes with heparin-coated cardiopulmonary bypass circuits: systematic review and meta-analysis. Ann Thorac Surg. 2015;100(5):1825-1833.
Yoshizaki T, Tabuchi N, van Oeveren W, et al. PMEA polymer coated PVC tubing maintains anti thrombogenic properties during in vitro whole blood circulation. Int J Artif Organs. 2005;28(8):834–840. doi:10.1177/039139880502800809
Hosoyama K, Ito K, Kawamoto S, et al. Poly(2-methoxyethylacrylate)-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery. J Artif Organs. 2016;19(3):233–240. doi:10.1007/s10047-016-0913-1.
Bender M, Zacharowski K, Aluffi E, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion. 2002;17(6):298–304. doi:10.1191/0267659102pf602oa.
Zhang M, Chan CHH, Pauls JP, et al. Investigation of heparin loaded poly(ethylene glycol)-based hydrogels as anti-thrombogenic surface coatings for extracorporeal membrane oxygenation. J Mater Chem B. 2022;10:4974–4983. doi:10.1039/D2TB00379A
Bhattacharjee A, Savargaonkar AV, Tahir M, et al. Surface modification strategies for improved hemocompatibility of polymeric materials: a comprehensive review. RSC Adv. 2024;14:7440–7458. doi:10.1039/D3RA08738G.
Lee DU, Kayumov M, Park J, et al. Antibiofilm and antithrombotic hydrogel coating based on superhydrophilic zwitterionic carboxymethyl chitosan for blood-contacting devices. Bioact Mater. 2024;34:112–124. doi:10.1016/j.bioactmat.2023.12.009.
Song X, Man J, Qiu Y, et al. High-density zwitterionic polymer brushes exhibit robust lubrication properties and high antithrombotic efficacy in blood-contacting medical devices. Acta Biomater. 2024;178:111–123. doi:10.1016/j.actbio.2024.02.032.
Wang H, Li N, Chen C, Yang D, Li K, Wang M, Wei M, Yang X, Song L, Yang M. Durable heparin/zwitterion composite coatings for enhanced hemocompatibility and antibacterial performance. J Mater Chem B. 2025;13:14704–14717. doi:10.1039/D5TB01660F.
Li R, Xu J, Li Y, et al. An endothelium membrane mimetic antithrombotic coating enables safer and longer extracorporeal membrane oxygenation application. Acta Biomater. 2024; 186:185–200. doi: 10.1016/j.actbio.2024.07.058.
Wei Y, Jiang H, Chai C, et al. Endothelium-Mimetic Surface Modification Improves Antithrombogenicity and Enhances Patency of Vascular Grafts in Rats and Pigs. JACC Basic Transl Sci. 2023;8(7):843-861. doi:10.1016/j.jacbts.2022.12.009
Ashcraft M, Garren M, Lautner-Csorba O, et al. Surface engineering for endothelium-mimicking functions to combat infection and thrombosis in extracorporeal life support technologies. Adv Healthc Mater. 2024;13(22): e2400492. doi:10.1002/adhm.202400492.
Are there sufficient standards for the in vitro hemocompatibility testing of biomaterials. Biointerphases. 2021;16:041001. doi:10.1116/6.0001317
Kamata K, Hatanaka Y, Tanaka H, et al. In vitro blood compatibility evaluation method: incubating while rotating hemodialyzers filled with fresh human blood. J Artif Organs. 2021; 24:412-416. doi:10.1007/s10047-020-01224-6
Weber M, Steinle H, Golombek S, Hann L, Schlensak C, Wendel HP, Avci-Adali M. Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility. Front Bioeng Biotechnol. 2018; 6:99. doi:10.3389/fbioe.2018.00099
Bender M, Zacharowski K, Aluffi E, et al. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg. 2002;16(3):342-348. doi:10.1016/S1010-7940(01)01160-4.
Kim J, Kim G, Lim J, et al. Comparative study on the responsiveness of different species to coagulation and complement for hemocompatibility evaluation. Appl Sci. 2024;14(15):6721. doi:10.3390/app14156721
Li R, Yin Li, Bai Y, et al. Achieving superior anticoagulation of endothelial membrane mimetic coating by heparin grafting at zwitterionic biocompatible interfaces. Int J Biol Macromol. 2023;257:128574. doi:10.1016/j.ijbiomac.2023.128574
Wen J, Huang S, Hu Q, et al. Recent advances in zwitterionic polymers based non fouling coating strategies for biomedical applications. Materials Today Chem. 2024; 40:102232. doi:10.1016/j.mtchem.2024.102232
Wendel HP, Ziemer G. Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg. 1999;16(3):342–350. doi:10.1016/S1010-7940(99)00210-9
ISO 10993-4:2017. Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood. International Organization for Standardization; 2017.
Patel M, Parrish A, Serna C 3rd, et al. Molecular biomarkers for in vitro thrombogenicity assessment of medical device materials. J Biomed Mater Res B Appl Biomater. 2024;112(10):e35491. doi:10.1002/jbm.b.35491.
Kalambokis GN, Oikonomou A, Baltayiannis G, Christou L, Kolaitis NI, Tsianos EV. Thrombin generation measured as thrombin–antithrombin complexes predicts clinical outcomes in patients with cirrhosis. Hepatol Res. 2016;46(3):E36–E44. doi:10.1111/hepr.12520.
Zipperle J, Falkensteiner N, Bihari D, et al. Effect of unfractionated heparin dose on complement activation and selected extracellular vesicle populations during extracorporeal membrane oxygenation. Int J Mol Sci. 2024;25(20):11166. doi:10.3390/ijms252011166.
Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: Part 1—mechanisms of inflammation. Ann Thorac Surg. 2009;87(4):1361-1370. doi:10.1016/j.athoracsur.2008.12.020.
Dufour N, Radjou A, Thuong M, et al. Hemolysis and plasma free hemoglobin during extracorporeal membrane oxygenation support: from clinical implications to laboratory details. ASAIO J. 2020;66(3):239–246. doi:10.1097/MAT.0000000000000974
Benčina M, Rawat N, Paul D, et al. Enhanced hemocompatibility and cytocompatibility of stainless steel. ACS Omega. 2024;9(17):19566–19577. doi:10.1021/acsomega.4c01191.
Stang K, Krajewski S, Neumann B, et al. Hemocompatibility testing according to ISO 10993-4: Discrimination between pyrogen- and device-induced hemostatic activation. Mater Sci Eng C. 2014;42:422–428. doi:10.1016/j.msec.2014.05.070
İndir
Yayınlanmış
Nasıl Atıf Yapılır
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2026 Acta Medica Ruha
Bu çalışma Creative Commons Attribution 4.0 International License ile lisanslanmıştır.
